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HIV-1 can move directly between T cells via virological synapses (VS). Although aspects of the molecular
and cellular mechanisms underlying this mode of spread have been elucidated, the outcomes for
infection of the target cell remain incompletely understood. We set out to determine whether HIV-1
transfer via VS results in productive, high-multiplicity HIV-1 infection. We found that HIV-1 cell-to-cell
spread resulted in nuclear import of multiple proviruses into target cells as seen by ﬂuorescence in-situ
hybridization. Proviral integration into the target cell genome was signiﬁcantly higher than that seen in a
cell-free infection system, and consequent de novo viral DNA and RNA production in the target cell
detected by quantitative PCR increased over time. Our data show efﬁcient proviral integration across VS,
implying the probability of multiple integration events in target cells that drive productive T cell
infection.
& 2013 Published by Elsevier Inc.Background
The human immunodeﬁciency virus type-1 (HIV-1) can spread
with high efﬁciency by moving directly between infected and
uninfected immune cells at the site of cell–cell contact, thereby
obviating rate-limiting ﬂuid-phase diffusion (Sattentau, 2008).
This type of cell-to-cell movement has been studied in most detail
in the principal HIV-1 target cell, the CD4+ T lymphocyte, and
functions predominantly via formation of intercellular contacts
termed virological synapses (VS) (Sattentau, 2008). VS are related
to, but distinct from, immunological synapses (Vasiliver-Shamis
et al., 2009,2010,2008) and consist of polarized multimolecular
structures containing adhesion molecules, viral envelope glyco-
proteins (Env) and viral receptors (Jolly et al., 2004; Piguet and
Sattentau, 2004; Sattentau, 2008). Direct cell-to-cell movement of
HIV-1 is more efﬁcient than its cell-free counterpart (Chen et al.,
2007; Martin et al., 2010; Mazurov et al., 2010; Sourisseau et al.,
2007), and may be of particular signiﬁcance in viral dissemination
in secondary lymphoid tissues that are densely packed with CD4+
T cells (Haase, 1999; Rudnicka et al., 2009). Both transmitted CCR5
tropic (R5) and CXCR4 tropic (X4) HIV-1 strains establish VS and
spread in this way (Blanco et al., 2004; Hubner et al., 2009; Jolly
et al., 2004; Martin et al., 2010; Ruggiero et al., 2008; Sourisseaulsevier Inc.
. Russell).
.et al., 2007). It has, however, been suggested that the observed
viral uptake across the VS by endocytic mechanisms may not
necessarily result in a productive infection (Blanco et al., 2004;
Chen et al., 2007). Evidence for productive target cell infection
across a VS consists of imaging the activation of a HIV-1 long
terminal repeat driven ﬂuorescent-expression cassette within the
target cell (Ruggiero et al., 2008), activation of single cycle
replication-dependent reporter vectors (Mazurov et al., 2010)
and detection of de-novo synthesized viral DNA (Jolly et al.,
2007a, 2007b; Martin et al., 2010) or viral Gag (Sourisseau et al.,
2007) in infected-target cell conjugates. In additionDel Portillo
et al. (2011) recently showed, using ﬂuorescence in situ hybridiza-
tion (FISH), that multiple proviral integration events occurred per
cell as a result of transfer across VS. However, the fate of these
integrants and the subsequent infection state of the target cells
was not established.
The steps of viral infection of target cells via VS following HIV-1
genome reverse transcription, including nuclear import, integra-
tion and production of de-novo vRNA have not been dissected.
This is in large part due to the technical difﬁculties implicit in
studying new infectious events in a target cell that is closely
associated with a previously infected donor cell. Here we have
attempted to overcome these difﬁculties and further characterize
the fate of viral nucleic acid in the target cell after cell-to-cell
spread of HIV-1 using imaging and quantitative PCR assays and
show that viral transfer across VS leads to proviral integration
resulting in productive infection.
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VS-mediated HIV-1 spread results in transfer of multiple vDNA copies
into the nucleus
In previous analyses we demonstrated that both X4 and R5
HIV-1 isolates assemble VS between contacting infected and
uninfected, receptor-expressing T cells, resulting in de-novo synth-
esis of vDNA within target cells, and that this process is signiﬁ-
cantly more efﬁcient than cell-free virus infection (Jolly et al.,
2007a, 2007b; Martin et al., 2010). Although reverse transcription
of incoming genomic RNA is an indicator of infection, most vDNA
does not go on to integrate (Wu, 2008). Unintegrated vDNA is
relatively unstable and is ultimately degraded or diluted from
dividing cellular populations (Wu, 2008; Zhou et al., 2005).
To investigate the steps in HIV-1 infection subsequent to reverse
transcription following viral transfer across a VS, we carried out
FISH on donor–target T cell conjugates. A VS formed between
BaL-infected Jurkat.Tat.R5 cells (Jkt.R5Ba-L) and target A301.R5 cells
co-cultured for 1 h is shown in Fig. 1A, revealing the deﬁning
features that we previously demonstrated in VS formed by X4 HIV-
1-infected T cells (Jolly et al., 2004), namely colocalization of Gag
and Env on the donor cell and CD4 on the target cell. To establishFig. 1. Detection of HIV-1 antigens and nucleic acids in HIV-1 infected-target T cell conj
R5Ba-L with A301.R5 cells formed over 1 h, staining with mAbs speciﬁc for CD4 and gp1
centre of the cells by LSCM. Single colours are shown for each label followed by all colo
(3D recon). (B) 3D projections of FISH of vDNA in ACH-2 cells (left panel), JktIIIB (centre
Cells are stained with CellTracker Orange. (C) 3D projections of FISH of conjugates of Jk
stain and are blue. Target A301.R5 cells were pre-labelled with Cell Tracker orange to diff
total viral nucleic acids; bottom panel, vDNA only (RNase-treated). Target cells are outline
cells at the time points shown. Cell nuclei and cytoplasm were labelled as for (C). Top pa
are outlined with a white border.the system of FISH for HIV-1-infected CD4+ T cells, infected and
uninfected T cell lines were cocultured to form VS as described
above, then hybridized with probes generated from labelled
fragmented vDNA either after treatment with RNase to eliminate
intracellular vRNA, or without this treatment to reveal both vRNA
and vDNA. Single optical sections were acquired for analysis:
although this will modestly underestimate positive hybridization
signals as it does not account for the entire nuclear volume,
it eliminates false positives of FISH-labelled virions adherent to
the plasma or nuclear membranes, or viral cores within the
cytoplasm that superimpose over the nucleus. However, due to
ﬂattening of the cell and nucleus introduced by the FISH proces-
sing, we observed the majority of positive spots were within a
single optical slice (data not shown) and so limited our analysis to
this optical plane. Fig. 1B shows images from the ACH-2 T cell line
containing 1 proviral copy per cell (Clouse et al., 1989) as a
calibration control, and uninfected Jurkat cells and HIV-1 IIIB-
infected Jurkat cells (JktIIIB) as speciﬁcity controls. As anticipated,
most ACH-2 cells (stained with cell tracker orange) revealed single
spots suggestive of integrated provirus: the absence of spots in
the remaining cells was most likely the result of the signal not
being present in the nuclear volume imaged. Infected Jurkats
contained multiple spots and no hybridization signal was detectedugates. (A) The anatomy of the HIV-1Ba-L VS was probed by ﬁxing conjugates of Jkt.
20 and polyclonal anti-Gag p17/p24 and taking single optical sections through the
urs merged, and a three-dimensional reconstruction of x–y sections into a z-stack
panel) and uninfected Jurkat cells (right panel). White arrows point to FISH signals.
tIIIB-A301.R5 cells at the time points shown. Cell nuclei were labelled with TOTO-1
erentiate them from the infected cells, and label is visualized as magenta. Top panel,
d with a white border. (D) 3D projections of FISH of conjugates of Jkt.R5BaL-A301.R5
nel, total viral nucleic acids; bottom panel, vDNA only (RNase-treated). Target cells
Fig. 2. Quantiﬁcation of vDNA in target cell nuclei. Random ﬁelds from cocultures
of JktIIIB and A301.R5 cells were evaluated for the presence of vDNA in target cell
nuclei revealed by FISH at the times shown. (A) The bars represent the percentage
of all target cells containing one or more vDNA spots. Error bars represent 1 SD.
Statistical signiﬁcance was calculated using ANOVA with Bonferroni multiple
comparison post-test comparing each to time point 0 h, *p¼o0.05. (B) The
number of vDNA spots was counted in each positive target cell nucleus, and the
results presented as range and mean value.
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To investigate the kinetics of viral nucleic acid transfer across
VS, donor and target T cells mixed 1:1 were ﬁxed at various times
and probed. Target cells were distinguished by covalently labelling
the cytoplasmwith a stable ﬂuorescent dye (orange), and all nuclei
labelled with TOTO (blue) to conﬁrm the nuclear localization of
any FISH signal. To reveal total viral nucleic acid (vRNA and vDNA)
transfer across VS, we carried out FISH in the absence of RNase
treatment and analysed conjugates by laser scanning confocal
microscopy (LSCM) with 3D Z stack projections. At 1 h a few
conjugates had already formed, and a representative conjugate is
shown in Fig. 1C (target cell is surrounded by a white boundary).
Viral nucleic acid, most of which probably corresponds to genomic
vRNA, was concentrated at the interfaces between the donor and
target cells in the upper panels but no labelling was evident within
the target cells. At 3 h multiple speckles had appeared in the target
cell nuclei, and by 5 h distinct spots were observed. To visualize
vDNA alone, samples were treated with RNase prior to FISH. At 1 h
post-conjugate formation FISH signals corresponding to vDNA
were observed in donor cells but not target cells (Fig. 1C lower
panels). By 3 h small speckles colocalizing with target cell nuclei
were observed and by 5 h obvious spots of label were evident
within target cell nuclei, implying transfer of multiple proviral
DNAs with the potential for integration. For HIV-1Ba-L we had
previously observed slower transfer kinetics (Martin et al., 2010)
and therefore we imaged the cells only at 3 and 5 h. We saw a few
vDNA spots in target cells at 3 h and multiple vDNA spots at 5 h
post-conjugate formation (Fig. 1D). To quantify the level of viral
transfer across a VS resulting in vDNA production and nuclear
import, target cells containing positive nuclear hybridization
signals of RNase-resistant material were counted. At 1 h the
number of positive target cells was not signiﬁcantly above back-
ground (Fig. 2A). However by 3 h ∼15% of target cells contained a
positive FISH signal (p o0.05), reducing to ∼13% at 5 h (p o0.05).
The number of vDNA spots per infected target cell nucleus was
also determined. The mean number of spots at 3 h was 3.4 with a
range of 1–9, dropping slightly to 3 with a range of 1–6 at 5 h
(Fig. 2B). Thus the percentage of infected target cells and the
number of nuclear vDNA spots reached a maximum at 3 h,
presumably representing a plateau in the nuclear import of
proviral DNA. These data are consistent with those of Del Portillo
et al. (2011) who observed an average of 3.82 proviral copies 30 h
after co-culture, with the added advantage that our system
excludes cell-free vDNA signal as none is detectable within 6 h
(Fig. 5 and Martin et al. (2010).
HIV-1 cell-to-cell transfer results in vDNA integration
Although the FISH results revealed proviral nuclear import,
nuclear localization of vDNA does not demonstrate integration. We
therefore adopted a semi-quantitative (q)PCR method that speciﬁ-
cally ampliﬁes integrated vDNA, and applied this to conjugates of
JktIIIB or Jkt.R5Ba-L and A301.R5 target or A201 control cells. The
method was based on the linker-primer method of Vandegraaff et al.
(2001) that relies upon restriction digestion of cellular DNA with
NlaIII for which a conserved restriction site also contained within the
HIV-1 LTR exists. The advantage of this approach over the Alu PCR
method is that the NlaIII restriction site occurs more frequently
(o1 kb) in the genome than Alu sites which occur once every 2.5 kb
(Grover et al., 2004), therefore the distance between an HIV-1
integrant and a NlaIII site will be less allowing detection of more
integration events (Mantovani et al., 2006). Enzymatic digestion with
NlaIII results in a 5′ overhang that can be ligated with a linker that
contains a primer for the LTR, allowing ampliﬁcation of integrated
HIV-1 sequences. The original method was modiﬁed to allow qPCR
ampliﬁcation of integrated LTR subsequent to the nested PCRreaction, allowing semi-quantiﬁcation of the ﬁnal product. All signals
were normalized to the baseline level of signal produced in the HIV-
1-infected T cells-A201 control target cell conjugates at equivalent
time points. At 0 h a very low level of integrated vDNA was detected
in the JktIIIB-A301.R5 conjugates. However, over time the value
increased (Fig. 3), reﬂecting newly integrated vDNA in the A301.R5
target cells. If a maximum of 15% of target cells are infected (Fig. 2A),
this suggests that at 6 h each infected target cell may contain an
average of 1 integrated provirus. However this is likely to be an
underestimate since the qPCR method we have used will lose
efﬁciency relative to amplicon length, which will vary depending
upon the site of integration. When the infected and target cells were
separated by a transwell the level of integration remained signiﬁ-
cantly lower (po0.001 at 24 h) than the cell-to-cell co-culture
throughout the time course, further conﬁrming that cell-to-cell
contact increases proviral DNA transfer (Chen et al., 2007; Del
Portillo et al., 2011; Martin et al., 2010; Sourisseau et al., 2007).
When the co-culture was performed in the presence of the integrase
inhibitor Raltegravir the level of integrated vDNA remained low
throughout the time course conﬁrming the speciﬁcity of the integra-
tion PCR assay. Although the signal in the presence of Raltegravir
increased modestly over time, this was not signiﬁcant. We conclude
that this is probably detection of 2LTR circles, which increase in the
presence of Raltegravir (Buzon et al., 2010). Although these 2LTR
circles cannot be ampliﬁed by the ﬁrst round linker PCR reaction of
the integration assay (Vandegraaff et al., 2001) they are still ampliﬁ-
able by the second round nested reaction.
Fig. 3. qPCR for integrated proviral DNA. (A) Jurkat cells infected with HIV-1Ba-L or HIV-1IIIB were mixed with target A201 or A301.R5 cells for the times indicated in the
presence or absence of Raltegravir and with and without transwell separation, followed by lysis and extraction of DNA, then digestion to create fragments. Semi-quantitative
PCR was carried out using primers designed to selectively amplify integrated forms of HIV-1 DNA, and β-globin, as detailed in the methods. Values were normalised to
β-globin copy number and at each time point the control result using non-susceptible A201 was subtracted from the A301.R5 test result to remove any signal present in donor
cells. Results are expressed as abundance of HIV-1 copies per cell. Bars represent mean values from up to four independent experiments, and error bars represent SEM.
Statistical signiﬁcance was calculated using ANOVA with Bonferroni multiple comparison post-test comparing time points within the cell-to-cell samples and the 24 h time
point between with cell-to-cell, Raltegravir treated and the cell-free transwell samples. *p¼o0.05, **p¼o0.01, ***p¼ o0.001.
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A301.R5 conjugates (Fig. 3), which showed increased numbers of
copies of integrated DNA over time in the cell-to-cell conjugates,
which were completely abolished if the cells were separated by a
transwell or the cell-to-cell conjugates were co-cultured in the
presence of Raltegravir. We saw a much more modest signal in the
Jkt.R5Ba-L-A301.R5 conjugates than the JktIIIB-A301.R5 conjugates
which cannot be explained by differences in target cell co-receptor
expression or donor cell infection level, which were comparable
(Fig. 4). These observations support our previous results showing
that R5 HIV-1 infection kinetics via VS are slower than those of X4
HIV-1 (Martin et al., 2010).HIV-1 cell-to-cell transfer results in synthesis of vRNA
Although proviral integration indicates that a cell is stably
infected by HIV-1, this may not necessarily lead to a productive
infection. To investigate productivity of target cell infection, we
measured de-novo synthesis of total vDNA and vRNA using qPCR
with primers against HIV-1 pol as previously described (Jolly et al.,
2007a, 2007b; Martin et al., 2010). All signals were normalized to
the baseline level of signal produced in HIV-1-infected Jurkats-
A301.R5 conjugates in the presence of the blocking antibody
13B8.2 at equivalent time points. Fig. 5A shows increasing HIV-
1IIIB pol vDNA signal in target A301.R5 cells relative to β-globin that
became detectable at 6 h and was signiﬁcantly greater than
starting levels by 24 h post-cell mixing. We hypothesize that this
increase is due to vRNA transfer across the synapse, which then
undergoes reverse transcription and integration (Fig. 3). HIV-1IIIB
RNA levels increased over time similarly to those of vDNA but with
a delay, since there was no detectable increase over starting values
at 12 h, but a clear increase was observed at 24 h. Most likely the
increase in vRNA results from transcription of integrated provirus.
The delay in vRNA production compared to vDNA production is in
line with viral replication kinetics whereby vRNA is ampliﬁed from
integrated vDNA. HIV-1Ba-L showed a similar pattern (Fig. 5B), with
vDNA detectable at 12 h post-cell mixing which reached signiﬁ-
cance at 24 h and vRNA detectable at 24 h. At these early time
points we consider that we are not detecting a spreading infection
with a signiﬁcant cell-free infectious contribution, as no integra-
tion signal above background was detected in the presence of a
transwell at 24 h (Fig. 3), and we have previously shown a lack ofvDNA signal above background in similar cell-free infection
systems at 24 h (Martin et al., 2010).Discussion
Here we show that cell-to-cell infection of CD4+ T cells across
VS results in de-novo production of vDNA reverse transcripts, a
proportion of which integrates into the target cell chromatin with
greater efﬁciency than that seen following cell-free infection.
The kinetics and levels of vDNA detection we ﬁnd are consistent
with previous studies that quantiﬁed the appearance of de-novo
vDNA following both cell-free and cell-to-cell infection.
Vandegraaff et al. (2001) showed detection of proviral integrants
at 4 h post high-multiplicity infection of a CD4+ T cell line, similar
to our ﬁrst signiﬁcant detection at 6 h and Del Portillo et al. (2011)
showed an average of 3.82 proviral copies per cell in line with our
estimated 3.4 proviral copies. Analysis of vRNA revealed a time-
dependent increase consistent with a productive infection of the
target cells.
These results add weight to the concept that HIV-1 spread across T
cell VS results in productive infection of CD4+ T cells, and provide
direct evidence to support the idea that VS-mediated spread of HIV-1
is likely to result in super-infection of individual CD4+ T cells leading to
multiple integration events. Multiple HIV-1 proviruses per cell have
been observed ex-vivo by FISH analysis in CD4+ splenocytes in situ
(Jung et al., 2002), and inferred by sequence analysis of viral
quasispecies within individual CD4+ T cells (Jung et al., 2002) and in
sections of spleens (Gratton et al., 2000) from HIV-1-infected indivi-
duals. A high proportion of HIV-1-infected T cells containing multiple
proviral genomes is consistent with the high multiplicity of infection
imparted to a permissive target cell by directed cell-to-cell spread
(Dimitrov et al., 1993; Dixit and Perelson, 2004; Martin et al., 2010), as
opposed to the predicted low multiplicity imparted by cell-free
infection that is limited by ﬂuid-phase diffusion and a high rate of
viral dissociation from the target cell (Platt et al., 2010). Our data are
therefore in line with models implying that cell-to-cell spread of HIV-1
in man and SIV in non-human primates is a dominant mode of viral
dissemination within secondary lymphoid tissue (Grossman et al.,
1998; Haase, 1999; Reilly et al., 2002). In this context it has recently
been shown in a bone marrow/liver/thymus (BLT) humanized mouse
model that HIV-1 induces a partial reduction in the motility of infected
T cells allowing more time for VS to form while not signiﬁcantly
Fig. 4. Cell surface expression level or HIV-1 receptor and co-receptors and
infection level of donor cells. (A) Infected JktIIIB and uninfected control Jurkat cells
were stained with KC57-FITC for HIV-1 Gag detection. (B) Infected Jkt.R5Ba-L and
uninfected control Jurkat cells were stained with KC57-FITC for HIV-1 Gag
detection. (C) Target A301.R5 cells were stained for CD4, CXCR4 and CCR5. As a
control A301.R5 cells were stained with secondary antibody only.
Fig. 5. qPCR for vDNA and vRNA. (A) JktIIIB were mixed with target A301.R5 cells for
the times indicated, followed by lysis and extraction of total DNA and RNA.
Quantitative PCR was carried out on DNA using pol-speciﬁc primers and normalized
to the signal obtained with β-globin primers. The amount of HIV-1IIIB RNA was
assayed by qRT-PCR using pol speciﬁc primers normalized against cellular β-actin.
The means of 3 independent experiments normalised to the 0 h time point in the
presence of 13B8.2 are shown, error bars represent SEM. Statistical signiﬁcance was
calculated using ANOVA with Bonferroni multiple comparison post-test comparing
each to 0 h. **p¼o0.01, ***p¼ o0.001. (B) As in (A) except that Jkt.R5BaL were
mixed with A301.R5 cells for the times indicated. The means of 3 independent
experiments normalized to the 0 h time point in the presence of 13B8.2 are shown.
Statistical signiﬁcance was calculated using ANOVA with Bonferroni multiple
comparison post-test comparing each to 0 h. *p¼o0.05, ***p¼o0.001.
R.A. Russell et al. / Virology 443 (2013) 143–149 147reducing the dissemination of these T cells throughout the body
(Murooka et al., 2012). This observation suggests that the formation of
VS and the subsequent viral transfer is a characteristic of optimal
in vivo HIV-1 infection. These ﬁndings not only have implications for
potential multiple integration events leading to recombination
amongst distinct viral genomes, but also for reduced sensitivity of
HIV-1 to antiretroviral therapy, which decreases as a function of
increasing multiplicity (Sigal et al., 2011).
A caveat of the current analysis is that we have used trans-
formed CD4+ T cell lines as donor and target cells. Although cell
lines are generally accepted as appropriate model systems for
analysis of HIV-1 cell-to-cell transfer (Blanco et al., 2004; Chen
et al., 2007; Hubner et al., 2009; Martin et al., 2010; Mazurov et al.,
2010; Puigdomenech et al., 2009; Sato et al., 1992), their consti-
tutively activated status means that they are poorly representative
of naïve and quiescent memory CD4+ T cell populations. In this
case the particular cell lines used have previously been shown to
form VS with the same gp120-receptor and adhesion moleculeinteractions as those seen in primary cell VS (Jolly et al., 2007a;
Rudnicka et al., 2009), giving conﬁdence that our data are
generally representative of a T cell VS. Since HIV-1 reverse
transcription, vDNA stability, proviral integration and subsequent
viral replication steps are dependent upon T cell activation state
(Arﬁ et al., 2009; Manganaro et al., 2010; Vatakis et al., 2009;
Zhou et al., 2005), however, future studies should consider the role
of cell-to-cell spread in the infection of primary CD4+ T cells in
various states of activation. Moreover, since VS can form between
cells other than T cells, and have been described for HIV-1 spread
between DCs and T cells (Larsson, 2005) and macrophages and
T cells (Groot et al., 2008) analysis of integration dynamics in these
systems will be revealing.Conclusions
The results presented here reveal that viral spread across a
T cell to T cell VS leads to the transfer of multiple copies of HIV-1
vRNA into the target cell, followed by reverse transcription,
integration and establishment of a productive infection. This not
only conﬁrms that HIV-1 cell-to-cell spread is highly efﬁcient and
productive, but also provides a mechanism for recombination
between distinct HIV-1 genomes within multiply infected cells.Materials and methods
Cells and viruses
Jurkat E6.1 and Jurkat.Tat.R5 cells (Morcock et al., 2005) were from
the NIBSC Centre for AIDS Reagents (CFAR) and were maintained in
R.A. Russell et al. / Virology 443 (2013) 143–149148growth medium (GM): RPMI+10% foetal calf serum and 100 U/mL
penicillin and 100 μg/mL streptomycin. Jurkat.Tat.R5 cells were main-
tained in 1 mg/mL G418 prior to infection. Virus isolates HIV-1IIIB and
HIV-1Ba-L were obtained from the CFAR, (NIBSC) UK. Jurkat E6.1 cells
were infected with HIV-1IIIB (JktIIIB), and Jurkat.Tat.R5 cells were
infected with HIV-1Ba-L (Jkt.R5Ba-L) for 7–10 days at which time Env
and Gag expression were highest as measured by ﬂow cytometry as
previously described (Martin et al., 2010) (Fig. 4A and B shows Gag
expression at day 7). Target cells were A301.R5, which express CD4,
CXCR4 and CCR5 (Fig. 4C) and are therefore permissive to both X4 and
R5 HIV-1 infection, and control A201 cells which lack CD4 and CCR5
(Jolly et al., 2007a, 2007b; Martin et al., 2010). Both were maintained
in GM; A301.R5 cells were also maintained in 1 mg/mL G418 prior to
infection.
Immunoﬂuorescent labelling and laser scanning confocal microscopy
(LSCM)
Jkt.R5Ba-L cells were mixed with target A301.R5 cells pre-labelled
with the non-blocking CD4 mAb L120 (CFAR) and co-cultured for the
times shown prior to ﬁxation in 1% formaldehyde as described
previously (Martin et al., 2010). Cells were labelled with mAb to
Env (2G12, CFAR) and rabbit anti-Gag p24/p17 (CFAR), counterstained
with anti-mouse Alexa 488 (Invitrogen, UK), anti-human-TRITC and
anti-rabbit Cy5 (Jackson-Immunotech, UK) and mounted on glass
slides using Pro-Long Gold (Invitrogen, UK). Images were acquired
using a Zeiss Pascal Axiovert 200M using sequential capture to avoid
channel cross-talk, and processed using Adobe Photoshop CS2.
Fluorescence in-situ hybridization (FISH)
The DIG-Nick Translation mix (Roche) was used to generate
digoxigenin-11-dUTP-labelled probes from the NL4.3 HIV-1 plas-
mid. DIG-Nick translation mix (4 mL) was added to 1 mg of pNL4.3
in 16 mL distilled (d)H2O. The sample was incubated for 90 min at
15 1C then placed on ice. At various times 3 mL aliquots of the
sample were mixed with loading buffer, denatured at 95 1C for
3 min, cooled for 3 min and run on a 1% agarose gel to determine
fragment lengths of the labelled probe. Probe lengths between 200
and 500 nucleotides were diluted in 1 mL 0.5 M EDTA (pH 8.0) and
the sample heated to 65 1C for 10 min. Unincorporated free
ﬂuorophore-dNTPs were removed with the Qiagen PCR puriﬁca-
tion kit. Gene frames (11 cm2, AbGene) on poly-L-Lysine-coated
glass slides were washed with distilled (d)H2O and air-dried.
Target A301.R5 cells were labelled with cell tracker orange
(Invitrogen), washed and resuspended in RPMI-1640 with 1%
FCS. Infected cells (2105 JktIIIB or Jkt.R5Ba-L) were washed in
PBS and mixed with an equal number of labelled A301.R5 cells.
and 100 mL of the cell mixture was applied to the poly-L-lysine
treated slides. Slides were incubated at 37 1C in high humidity for
1, 3, and 6 h, ﬁxed with 4% paraformaldehyde in PBS for 15 min at
4 1C and cells permeabilized with 0.2% Triton-X100 in PBS for
10 min at RT. For detection of DNA only cells were treated with
100 mg/mL RNAase for 30 min at 37 1C before adding 2 SSC for
5 min at RT. Slides were dehydrated at −20 1C through an ethanol
series and air dried. Probe mix was 10 ng digoxigenin-labelled
probe in 50% formamide, 2 SSC, 10% dextran sulphate, 1 mg
salmon sperm DNA, 10 mg yeast tRNA and 5 mg Cot1 DNA made
up to a total of 15 mL per slide in dH2O. Probe mix was added to the
slides and sealed before denaturation at 94 1C for 4 min. Slides
were placed at 37 1C for 3 h, unsealed and washed at 37 1C:
215 min in 55% formamide, 2 SSC buffer, 10 min in 2 SSC
buffer 25 min 0.25 SSC buffer. Slides were blocked in 1% BSA,
4 SSC buffer with 0.1% Tween-20. The probe was detected with
1:25,000 sheep anti-digoxigenin antibody (Thermo Scientiﬁc)
and 1:500 anti-sheep Alexa 488. Slides were washed 3 in 0.1%tween, 2 SSC buffer containing 1:5000 TOTO-1 (Invitrogen) and
mounted in Vectashield (Vectorlabs). For quantiﬁcation of HIV-1
proviral copies by FISH, random ﬁelds were scored for number of
target cells, number of target cells with spots, and number of spots
per positive cell. Results were expressed as percentage of target
cells with spots and number of spots per positive target cell.
qPCR for integrated proviral DNA
The method is based on (Vandegraaff et al., 2001). Primers were
designed to detect both HIV-1IIIB and HIV-1Ba-L sequences from the
LANL database (www.hiv.lanl.web). Primer sequences were as follows:
LPNV–TCATGATCAATGGGACGATCACATG, U3NV–GTGTAACAAG-
CAGTTGTTCTCTCC, HIVuniversalF–GGAAGGGCTAATTCACTC, HIVuni-
versalR–CACCATCCAAAGGTCAGTGG, β-globin-S–AACTGGGCATGTGGA
GACAGA, β-globin AS–CTAAGGGTGGGAAAATAGACCAATAG. For each
sample, 5105 infected cells were mixed with 5105 target A301.R5
cells in 300 mL GM per well of 96-well plates. Plates were incubated at
37 1C in 5% CO2. At appropriate time points cells were pelleted,
supernatant aspirated, and pellets frozen at −80 1C for DNA extraction
using DNeasy Blood and Tissue Kit (Qiagen). For the ﬁrst restriction
digest, 10 OPA+ buffer was prepared: 1 M potassium acetate,
250 mM tris-acetate, 100 mM magnesium acetate, 5 mM β-mercap-
toethanol, 100 mg/mL BSA in dH2O. Isolated chromosomal DNA (2.5 mL)
was digested to completion for 3 h at 37 1C with 20 U of BglII (New
England Biolabs) in 2 OPA+ buffer in 20 mL. The second digest was
performed in a volume of 40 mL for 3 h at 37 1C in a ﬁnal buffer of
1 OPA+, 100 mg/mL BSA,1 mM dithiothreitol and 10 U of NlaIII (New
England Biolabs). Two nucleotides (G and A) of the BglII overhang
generated by digestion were ﬁlled in by adjusting the sample to ﬁnal
concentrations of 7.5 mM dithiothreitol, 0.25 mM dGTP (Promega),
0.25 mM dATP (Promega) and 5 U of Klenow (New England Biolabs) in
50 mL for 30 min at 37 1C, and excess dNTPs were removed with a
QiaQuick PCR Clean-up kit (Qiagen). Linker ligation was carried out by
resuspending DNA in 10 mL ligation buffer (1 in ﬁnal volume, New
England Biolabs) and 50 pmol of LPNV made up to 100 mL in dH2O.
Samples were heated to 60 1C for 10 min to anneal the primer, then
snap-cooled on ice to minimize inter- and intramolecular ligation of
NlaIII fragments. T4 DNA ligase (400 U, New England Biolabs) was
added and samples incubated overnight at 16 1C. For the ﬁrst round
PCR, 1 PCR Buffer II (Applied Biosystems) was mixed with 2 mM
MgCl2 and 0.2 mM deoxynucleoside triphosphates (dNTPs) (Promega).
50 pmol of LPNV and 100 pmol of U3NVwere added along with 5 U of
AmpliTaq Gold DNA Polymerase (Applied Biosystems) and the ﬁnal
volume was adjusted to 100 mL. The PCR was cycled as follows:
denaturation at 95 1C, 12 min; 22 cycles, 94 1C; denaturation 30 s,
primer annealing at 58 1C, 30 s, extension 72 1C, 1 min; ﬁnal extension
72 1C, 10 min. Nested qPCR was as follows. 6 mM each forward and
reverse primers were mixed with 1 MESA Green qPCR mastermix
(Eurogentec) and a standard curve constructed using ABI7500 soft-
ware. All qPCRs were cycled on the Applied Biosystems 7500 as
follows: 50 1C, 2 min; 95 1C, 10 min; 40 cycles, 95 1C, 15 s followed by
60 1C, 1 min. Values were normalized to hbb copy number in the
starting sample, determined using SYBR green detection with β-
globin-S and β-globin-AS primers in place of HIV primers.
qPCR for viral (v)RNA and vDNA
Jkt.R5Ba-L and JktIIIB cells were co-cultured with A301.R5 cells
for the times shown 710 μg/mL blocking CD4 antibody 13B8.2
(Beckman Coulter). At each time point cells were pelleted, super-
natant discarded and DNA and RNA extracted using the Illustra
TriplePrep Kit (GE Healthcare). HIV-1 DNA was quantiﬁed using
the HIV-1Ba-L pol primer/probe set (Martin et al., 2010) and the
β-globin internal control primer/probe set. HIV-1 RNA was quan-
tiﬁed using Superscript III First Strand Synthesis SuperMix
R.A. Russell et al. / Virology 443 (2013) 143–149 149(Invitrogen) for cDNA production followed by the HIV-1 pol primer
probe set and the β-actin internal control primer set (Eurogentec)
with SybrGreen detection. As a control for DNA contamination,
cDNA production was carried out in the absence of reverse
transcriptase and the resulting mix was used in the qPCR reaction:
no signal was detected conﬁrming the absence of any DNA
contamination (data not shown).
Statistical analysis
FISH results were analysed using ANOVA with Bonferroni
multiple comparison post-test comparing all samples to the 0 h
time point and an unpaired two-tailed t-test comparing the 3 and
5 h time points. Results of the integration PCR, the qPCR and the
qRT-PCR on the integrated DNA, the total vDNA and the vRNA,
respectively, were analysed using ANOVAwith Bonferroni multiple
comparison post-test to compare all samples to the 0 h time point
unless otherwise stated in the ﬁgure legends.Authors' contributions
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